Avaxim

Avaxim is a vaccine designed to protect against hepatitis A, a viral infection affecting the liver. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous injection.

Avaxim is primarily used for the prevention of hepatitis A, a contagious liver disease caused by the hepatitis A virus. It is often recommended for individuals traveling to regions with high rates of hepatitis A, as well as for those who may be at increased risk due to their occupation or lifestyle. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing long-term protection.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience temporary fatigue, headache, or low-grade fever. These effects are generally mild and resolve within a few days. Serious side effects are rare but should be reported to a healthcare professional.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine, including neomycin, should avoid Avaxim. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine. Pregnant or breastfeeding women should consult their healthcare provider before use.

Avaxim may interact with certain medications or other vaccines. It is generally safe to receive Avaxim at the same time as other vaccines, but this should be discussed with a healthcare provider. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness. Always inform your healthcare provider about all medications and supplements you are taking.